Drug Database
Back to search

Poland· PL-100108409

Apo-Flutam

A flutamide product containing flutamidum, registered in Poland by Aurovitas Pharma Polska Sp. z o.o.. The same ATC class is registered in 10 of our 19 countries.

ATC L02BB01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedApo-FlutamATCL02BB01REGISTER NO.PL-100108409PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about flutamidumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Flutamide is registered in 10 of 19 countries.

Countries holding a registration under ATC L02BB01 (flutamide), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose
Search flutamide products by name

Flutamide · ATC L02BB01

10 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Germany
  • Italyprice
  • Polandprice
  • Spainprice
  • Sweden
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of flutamide costs, country by country.

Normalised to the WHO defined daily dose (0.75 g), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Flutamide · price per daily dose (0.75 g)

USD · FX 28 Sept 2026

  • IT Italy$2.44
  • ES Spain$2.04
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Flutamidum
Manufacturer
Aurovitas Pharma Polska Sp. z o.o.
Country
Poland (PL)
ATC code
L02BB01
ATC class
Flutamide
Defined daily dose
0.75 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

2 priced
  • gtin
    05909990941612
    30 szt.
    PLN 24.28
  • gtin
    05909990941629
    90 szt.
    PLN 65.85
  • gtin
    05909991446192
  • gtin
    05909991446208

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

357 interactions on record for flutamide.

Graded by severity as the source publishes them — 78 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check flutamide against other medicinesHow interaction checks work

Flutamide · interactions on record

357 records

  • 78 severe
  • 244 moderate
  • 5 minor
  • 30 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • QuinidineC01BA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Flutamide in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All flutamide products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Cyprus · Flutan
  • Germany · Fluta, Flutamid Al
  • Denmark · Fluprosin
  • Spain · Flutamida Cinfa, Prostacur
  • United Kingdom (Northern Ireland) · Flutamide Activase Pharmaceuticals, Flutamide Generics [uk]
  • Greece · Rosiniol
  • Italy · Flutamide Eg
  • Latvia · Flutan
  • Malta · Flutan
  • Portugal · Prosneo
  • Romania · Flutan
  • Sweden · Flutamid Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ed3266a9-4296-429a-9cfb-388a7224ccec
GET /v1/drugs/ed3266a9-4296-429a-9cfb-388a7224ccec?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "250 mg",
  "packaging": "05909990941612 ¦ Rp ¦ 19341\n30 tabl.\n05909990941629 ¦ Rp ¦ 19342\n90 tabl.\n05909991446192 ¦ Rp ¦ 138942\n60 tabl.\n05909991446208 ¦ Rp ¦ 138943\n100 tabl.",
  "substance": "Flutamidum 250 mg",
  "common_name": "Flutamidum",
  "pl_product_id": "100108409",
  "pozwolenie_nr": "09416",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about flutamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console